title: Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
authors.forename: C
authors.initials: C
authors.lastname: Girard
authors.forename: D
authors.initials: D
authors.lastname: Bessis
authors.forename: V
authors.initials: V
authors.lastname: Blatìre
authors.forename: J J
authors.initials: JJ
authors.lastname: Guilhou
authors.forename: B
authors.initials: B
authors.lastname: Guillot
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin